Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

James Sickler

Optometrist Medina, NY Doctor of Optometry

NPI 1922256205 CMS profile 1186579

500 Erie St, Medina, NY 14103

Open in the dashboard

General payments

$2,650

22 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, James Sickler of Medina, NY is reported in the CMS Open Payments database as having received $2,650 across 22 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $62 3
2024 General $2,251 11
2023 General $214 3
2022 General $28 2
2020 General $17 1
2019 General $77 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Sickler
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to James Sickler were reported at $62. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year James Sickler Optometrist median Middle half National median
2019 $77 $159 $67–$371 $163
2020 $17 $72 $29–$165 $114
2021 $0 $125 $46–$292 $132
2022 $28 $162 $66–$374 $149
2023 $214 $177 $72–$406 $160
2024 $2,251 $188 $77–$427 $164
2025 $62 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. TissueTech, Inc. $2,336 12 payments
  2. CooperVision Inc. $105 1 payment
  3. Sight Sciences, Inc. $64 1 payment
  4. AbbVie, Inc. $62 3 payments
  5. Alcon Vision LLC $24 1 payment
  6. Ivantis, Inc $17 1 payment
  7. Oyster Point Pharma, Inc. $15 1 payment
  8. Novartis Pharmaceuticals Corporation $14 1 payment
  9. Shire North American Group Inc $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $1,550 4 payments
  2. Food and Beverage $1,100 18 payments
Products named General payments · program years 2019–2025
  1. MyDay Contact Lens $105 1 payment
  2. PROKERA $86 1 payment
  3. AMNIOGRAFT $86 1 payment
  4. OMNI $64 1 payment
  5. DURYSTA $62 3 payments
  6. HYDRUS Microstent $24 1 payment
  7. Hydrus $17 1 payment
  8. TYRVAYA $15 1 payment
  9. XIIDRA Ophthalmology $14 1 payment
  10. XIIDRA Opthalmics $13 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

295

Median for Optometry: 120

Drug cost

$18,936

Median for Optometry: $8,864

Branded share of claims

34.6%

Median for Optometry: 24.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Lumigan Bimatoprost Brand 18 $10,624
Travoprost Generic 16 $2,324
Prednisolone Acetate Generic 42 $1,976
Latanoprost Generic 109 $1,587
Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha Brand 71 $852
Timolol Maleate Generic 12 $778
Brimonidine Tartrate Generic 14 $626
Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat Brand 13 $168

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 27,653 Part D prescribers listed as Optometry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 20 billing codes

Paid by Medicare

$38,898

Medicare's payments for the services billed

Medicare patients

317

Average age 70

Services billed

549

173 women, 144 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 72%
Arthritis 38%
Diabetes 32%
Chronic kidney disease 27%
Ischemic heart disease 26%
Depression 20%
COPD 17%
Osteoporosis 13%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

22 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record